{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:26:28Z","timestamp":1768249588591,"version":"3.49.0"},"reference-count":29,"publisher":"Societas Neurologica Japonica","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2009]]},"DOI":"10.5692\/clinicalneurol.49.576","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T14:51:22Z","timestamp":1307112682000},"page":"576-581","source":"Crossref","is-referenced-by-count":5,"title":["A 25-year-old woman with primary Sj&amp;ouml;gren syndrome who developed optic neuritis and encephalomyelitis associated with an anti-aquaporin 4 antibody"],"prefix":"10.5692","volume":"49","author":[{"given":"Hirotaka","family":"Kato","sequence":"first","affiliation":[{"name":"Department of Neurology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhei","family":"Ohnaka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Showa University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Alexander EL, Malinow K, Lejewski JE, et al: Primary Sj&ouml;gren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Int Med 1986; 104: 323-330","DOI":"10.7326\/0003-4819-104-3-323"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Weinshenker BG: Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol 2007; 64: 899-901","DOI":"10.1001\/archneur.64.6.899"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wingerchuk DM, Lennon VA, Lucchinetti CF, et al: The spectrum of neuromyelitis. Lancet Neurol 2007; 6: 805-815","DOI":"10.1016\/S1474-4422(07)70216-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ii Y, Shindo A, Sasaki R, et al: Reversible stenosis of large cerebral arteries in a patient with combined Sj&ouml;gren's syndrome and neuromyelitis optica spectrum disorder. Rheumatol Int 2008; 28: 1277-1280","DOI":"10.1007\/s00296-008-0611-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Konstantina GY, Athina KE, Kleanthis DK, et al: Neuromyelitis optica with coexisting autoimmune disorders. Arch Neurol 2008; 65: 995","DOI":"10.1001\/archneur.65.7.995-a"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Jorge CK, Meena G: Neuromyelitis optica and autoimmune diseases. Arch Neurol 2008; 65: 995-996","DOI":"10.1001\/archneur.65.7.996"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mehta LR, Samuelsson MK, Kleiner AK, et al: Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Mult Scler 2008; 14: 425-427","DOI":"10.1177\/1352458507084107"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Mizuno Y, Hara T, Hatae K, et al: Reccurent parotid gland enlargement as an initial manifestation of Sj&ouml;gren syndrome in children. Eur J Pediatr 1989; 148: 414-416","DOI":"10.1007\/BF00595900"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Alexander EL, Provost TT, Stevens MB, et al: Neurologic complications of primary Sj&ouml;gren's syndrome. Medicine (Baltimore) 1982; 61: 247-257","DOI":"10.1097\/00005792-198207000-00004"},{"key":"10","unstructured":"10) Alexander EL: Neurologic disease in Sj&ouml;gren's syndrome: mononuclear inflammatory vasculopathy affecting central\/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 1993; 19: 869-908"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Wingerchuk DM, Lennon VA, Pittock SJ, et al: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489","DOI":"10.1212\/01.wnl.0000216139.44259.74"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Lennon VA, Wingerchuk DM, Kryzer T, et al: A serum autoantibody marker of neuromyelis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Lennon VA, Kryzer TJ, Pittock SJ, et al: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477","DOI":"10.1084\/jem.20050304"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Wingerchuk DM, Hogancamp WF, O'Brien PC, et al: The clinical course of neuromyelitis. Neurology 1999; 53: 1107-1114","DOI":"10.1212\/WNL.53.5.1107"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mandler RN, Davis LE, Jeffery DR, et al: Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162-168","DOI":"10.1002\/ana.410340211"},{"key":"16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1212\/WNL.44.5.899","volume":"44","year":"1994","unstructured":"16) Alexander DM, Ranzenbach MR, Kumar AJ, et al: Anti-Ro (SSA) autoantibodies in central nervous system disease associated with Sj&ouml;gren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 1994; 44: 899-908","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"17","unstructured":"17) Harada T, Ohashi T, Miyagishi R, et al: Optic neuropathy and acute transverse myelopathy in primary Sj&ouml;gren's syndrome. Jpn J Ophthalmol 1995; 39: 162-165"},{"key":"18","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.54.6.1391","volume":"54","year":"2000","unstructured":"18) Mochizuki A, Hayashi A, Hisahara S, et al: Steroid responsive Devic's variant in Sj&ouml;gren's syndrome. Neurology 2000; 54: 1391-1392","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) G&ouml;kcay F, Celebisoy N, G&ouml;kcay A, et al: Primary Sj&ouml;gren's syndrome presenting as neuromyelitis optica. Pediatr Neurol 2007; 36: 58-60","DOI":"10.1016\/j.pediatrneurol.2006.07.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Misu T, Fujihara K, Kakitani A, et al: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-1234","DOI":"10.1093\/brain\/awm047"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Pittock SJ, Weinshenker BG, Lucchinetti CF, et al: Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63: 964-968","DOI":"10.1001\/archneur.63.7.964"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Pittock SJ, Lennon VA, Kreche K, et al: Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396","DOI":"10.1001\/archneur.63.3.390"},{"key":"23","doi-asserted-by":"publisher","unstructured":"24) McKeon A, Lennno VA, Lotze T, et al: CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71: 93-100","DOI":"10.1212\/01.wnl.0000314832.24682.c6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Steinfield S, Cogan E, King LS, et al: Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sj&ouml;gren's syndrome patients. Lab Invest 2001; 81: 143-148","DOI":"10.1038\/labinvest.3780221"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26) Agre P, King LS, Yasui M, et al: Aquaporin water channels-from atomic structure to clinical medicine. J Physiol 2002; 542: 3-16","DOI":"10.1113\/jphysiol.2002.020818"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Javed A, Balabanov R, Arnason BGW, et al: Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Mult Scler 2008; 14: 809-814","DOI":"10.1177\/1352458508088941"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28) Shimizu Y, Yokoyama K, Misu T, et al: Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 2008; 255: 305-307","DOI":"10.1007\/s00415-007-0730-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Papeix C, Vidal JS, de Seze J, et al: Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007; 13: 256-259","DOI":"10.1177\/1352458506070732"},{"key":"29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","volume":"51","year":"1998","unstructured":"30) Mandler RN, Ahmed W, Denocoff JE, et al: Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998; 51: 1219-1220","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u539f\u767a\u6027\u30b7\u30a7\u30fc\u30b0\u30ec\u30f3\u75c7\u5019\u7fa4\uff08SjS\uff09\u306b\u8996\u795e\u7d4c\u708e\u3068\u8133\u810a\u9ac4\u708e\u3092\u5408\u4f75\u3057\uff0c\u6297\u30a2\u30af\u30a2\u30dd\u30ea\u30f34\u6297\u4f53\u304c\u967d\u6027\u3067\u3042\u3063\u305f25\u6b73\u5973\u6027\u4f8b"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/49\/9\/49_9_576\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T11:25:31Z","timestamp":1560252331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/49\/9\/49_9_576\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.49.576","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}